COVID-19

Exciting breakthrough offers hope for Long COVID patients

Researchers from Griffith University’s National Centre for Neuroimmunology and Emerging Diseases (NCNED) have made a groundbreaking discovery that could bring relief to those struggling with Long COVID. In a world-first finding, they’ve identified a way to restore the faulty function of ion channels on immune cells using a well-known drug typically used for other medical […]
Published
Griffith Health

$438,000 grant to investigate ME/CFS progression

Researchers will track progression of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). 
Published
3 Good Health and Well Being

Health outcomes for Long COVID are comparable with ME/CFS

People with Long COVID in Australia have poor health outcomes that are comparable with another emerging disease known as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Published
3 Good Health and Well Being

Top Griffith scientists head to Canberra to make case for thousands with ME/CFS

Calls for new national clinical guidelines to improve the care of hundreds of thousands of Australians with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and potentially thousands more with Long Covid.
Published
17 Partnerships for the Goals

Largest medical research grant to help ME/CFS and Long COVID research

Griffith University’s research into the potential overlap between Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) has received a major boost thanks to a $6.4 million grant from the Stafford Fox Medical Research Foundation.
Published
3 Good Health and Well Being

World’s strongest MRI investigates COVID and myalgic encephalomyelitis/chronic fatigue impacts on the brain

In a world-first, Griffith University researchers have used an ultra-high field MRI (7 Tesla) to investigate how COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) mirror the same effects on the brain structure.
Published
Clem Jones Centre for Neurobiology and Stem Cell Research

Griffith joins $280 million partnership to deliver mRNA vaccine outcomes

Queensland will become a global mRNA vaccine hub with global healthcare company Sanofi partnering with Griffith University and other leading research institutions to establish a world-first research centre in south east Queensland.
Published